Product Name:1,4-Diisocyanatobutane

IUPAC Name:1,4-diisocyanatobutane

CAS:4538-37-8
Molecular Formula:C6H8N2O2
Purity:95%+
Catalog Number:CM343273
Molecular Weight:140.14

Packing Unit Available Stock Price($) Quantity
CM343273-25g in stock ŭƻȋ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:4538-37-8
Molecular Formula:C6H8N2O2
Melting Point:-
Smiles Code:O=C=NCCCCN=C=O
Density:
Catalog Number:CM343273
Molecular Weight:140.14
Boiling Point:
MDL No:MFCD00075559
Storage:

Category Infos

Aliphatic Chain Compounds
Aliphatic chain compounds include aliphatic compounds and chain compounds containing other elements or groups. Aliphatic hydrocarbons are hydrocarbons with the basic properties of aliphatic compounds. In aliphatic compounds, carbon atoms are arranged in straight chain, branched chain or cyclic, which are respectively called straight chain aliphatic hydrocarbons, branched chain aliphatic hydrocarbons and alicyclic hydrocarbons. Some cyclic hydrocarbons are different in nature from aromatic hydrocarbons, and are very similar to aliphatic hydrocarbons. Such cyclic hydrocarbons are called alicyclic hydrocarbons. In this way, aliphatic hydrocarbons become a general term for all hydrocarbons except aromatic hydrocarbons. Aliphatic hydrocarbons and their derivatives (including halogenated hydrocarbons) and alicyclic hydrocarbons and their derivatives are collectively referred to as aliphatic compounds.
Solar Cell Materials
Solar Cell Materials refers to the materials used in the construction and functioning of solar cells. These materials play a crucial role in converting sunlight into electrical energy through the photovoltaic effect. Some common solar cell materials include: perovskite-based solar cells (PSCs) materials, dye-sensitized solar cells (DSSCs) materials, organic photovoltaic (OPV) materials. It's important to note that ongoing research and development in solar cell materials aim to improve efficiency, reduce costs, and explore new alternatives for sustainable energy generation.

Column Infos

Tenapanor
FDA has approved XPHOZAH (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

XPHOZAH, with its unique blocking mechanism of action, acts locally in the gut to inhibit the sodium hydrogen exchanger 3 (NHE3), reducing phosphate absorption through the paracellular pathway, the primary pathway of phosphate absorption.